Michael S Wolf1,2, Terry C Davis3, Laura M Curtis4, Stacy Cooper Bailey5, JoAnn Pearson Knox6, Ashley Bergeron4, Mercedes Abbet6, William H Shrank7, Ruth M Parker8, Alastair J J Wood9. 1. Health Literacy and Learning Program, Division of General Internal Medicine, Feinberg School of Medicine at Northwestern University, 750 N. Lake Shore Drive, 10th Floor, Chicago, IL, 60611, USA. mswolf@northwestern.edu. 2. Department of Learning Sciences, School of Education and Social Policy, Northwestern University, Evanston, IL, USA. mswolf@northwestern.edu. 3. Department of Medicine-Pediatrics, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, USA. 4. Health Literacy and Learning Program, Division of General Internal Medicine, Feinberg School of Medicine at Northwestern University, 750 N. Lake Shore Drive, 10th Floor, Chicago, IL, 60611, USA. 5. Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina - Chapel Hill, Chapel Hill, NC, USA. 6. NoVA Scripts Central Pharmacy, Falls Church, VA, USA. 7. CVS/Caremark, Woonsocket, RI, USA. 8. Division of General Medicine, Emory University School of Medicine, Atlanta, GA, USA. 9. Department of Pharmacology, Weill Cornell Medical College, New York, NY, USA.
Abstract
BACKGROUND: Patient misunderstanding of prescription drug label instructions is a common cause of unintentional misuse of medication and adverse health outcomes. Those with limited literacy and English proficiency are at greater risk. OBJECTIVE: To test the effectiveness of a patient-centered drug label strategy, including a Universal Medication Schedule (UMS), to improve proper regimen use and adherence compared to a current standard. DESIGN: Two-arm, multi-site patient-randomized pragmatic trial. PARTICIPANTS: English- and Spanish-speakingpatients from eight community health centers in northern Virginia who received prescriptions from a central-fill pharmacy and who were 1) ≥30years of age, 2) diagnosed with type 2 diabetes and/or hypertension, and 3) taking ≥2 oral medications. INTERVENTION: A patient-centered label (PCL) strategy that incorporated evidence-based practices for format and content, including prioritized information, larger font size, and increased white space. Most notably, instructions were conveyed with the UMS, which uses standard intervals for expressing when to take medicine (morning, noon, evening, bedtime). MAIN MEASURES: Demonstrated proper use of a multi-drug regimen; medication adherence measured by self-report and pill count at 3 and 9 months. KEY RESULTS: A total of 845 patients participated in the study (85.6 % cooperation rate). Patients receiving the PCL demonstrated slightly better proper use of their drug regimens at first exposure (76.9 % vs. 70.1 %, p = 0.06) and at 9 months (85.9 % vs. 77.4 %, p = 0.03). The effect of the PCL was significant for English-speaking patients (OR 2.21, 95 % CI 1.13-4.31) but not for Spanish speakers (OR 1.19, 95 % CI 0.63-2.24). Overall, the intervention did not improve medication adherence. However, significant benefits from the PCL were found among patients with limited literacy (OR 5.08, 95 % CI 1.15-22.37) and for those with medications to be taken ≥2 times a day (OR 2.77, 95 % CI 1.17-6.53). CONCLUSIONS: A simple modification to pharmacy-generated labeling, with minimal investment required, can offer modest improvements to regimen use and adherence, mostly among patients with limited literacy and more complex regimens. Trial Registration (ClinicalTrials.gov): NCT00973180, NCT01200849.
RCT Entities:
BACKGROUND:Patient misunderstanding of prescription drug label instructions is a common cause of unintentional misuse of medication and adverse health outcomes. Those with limited literacy and English proficiency are at greater risk. OBJECTIVE: To test the effectiveness of a patient-centered drug label strategy, including a Universal Medication Schedule (UMS), to improve proper regimen use and adherence compared to a current standard. DESIGN: Two-arm, multi-site patient-randomized pragmatic trial. PARTICIPANTS: English- and Spanish-speaking patients from eight community health centers in northern Virginia who received prescriptions from a central-fill pharmacy and who were 1) ≥30 years of age, 2) diagnosed with type 2 diabetes and/or hypertension, and 3) taking ≥2 oral medications. INTERVENTION: A patient-centered label (PCL) strategy that incorporated evidence-based practices for format and content, including prioritized information, larger font size, and increased white space. Most notably, instructions were conveyed with the UMS, which uses standard intervals for expressing when to take medicine (morning, noon, evening, bedtime). MAIN MEASURES: Demonstrated proper use of a multi-drug regimen; medication adherence measured by self-report and pill count at 3 and 9 months. KEY RESULTS: A total of 845 patients participated in the study (85.6 % cooperation rate). Patients receiving the PCL demonstrated slightly better proper use of their drug regimens at first exposure (76.9 % vs. 70.1 %, p = 0.06) and at 9 months (85.9 % vs. 77.4 %, p = 0.03). The effect of the PCL was significant for English-speaking patients (OR 2.21, 95 % CI 1.13-4.31) but not for Spanish speakers (OR 1.19, 95 % CI 0.63-2.24). Overall, the intervention did not improve medication adherence. However, significant benefits from the PCL were found among patients with limited literacy (OR 5.08, 95 % CI 1.15-22.37) and for those with medications to be taken ≥2 times a day (OR 2.77, 95 % CI 1.17-6.53). CONCLUSIONS: A simple modification to pharmacy-generated labeling, with minimal investment required, can offer modest improvements to regimen use and adherence, mostly among patients with limited literacy and more complex regimens. Trial Registration (ClinicalTrials.gov): NCT00973180, NCT01200849.
Authors: Laura J Sahm; M S Wolf; L M Curtis; R Behan; M Brennan; H Gallwey; S Mc Carthy Journal: Eur J Clin Pharmacol Date: 2011-11-30 Impact factor: 2.953
Authors: Stacy Cooper Bailey; Urmimala Sarkar; Alice Hm Chen; Dean Schillinger; Michael S Wolf Journal: J Gen Intern Med Date: 2012-03-27 Impact factor: 5.128
Authors: Michael S Wolf; Paul Shekelle; Niteesh K Choudhry; Jessica Agnew-Blais; Ruth M Parker; William H Shrank Journal: Med Care Date: 2009-03 Impact factor: 2.983
Authors: William H Shrank; Jessica Agnew-Blais; Niteesh K Choudhry; Michael S Wolf; Aaron S Kesselheim; Jerry Avorn; Paul Shekelle Journal: Arch Intern Med Date: 2007-09-10
Authors: Sunil Kripalani; Rashanda Robertson; Melissa H Love-Ghaffari; Laura E Henderson; Jessica Praska; Akilah Strawder; Marra G Katz; Terry A Jacobson Journal: Patient Educ Couns Date: 2007-03-06
Authors: Alex Federman; Erin Sarzynski; Cindy Brach; Paul Francaviglia; Jessica Jacques; Lina Jandorf; Angela Sanchez Munoz; Michael Wolf; Joseph Kannry Journal: Int J Med Inform Date: 2018-09-15 Impact factor: 4.046
Authors: Denise D Tran; Patrick C M Brown; Corrin Murphy; Diana Ho; Karen A Hudson; Anna C Wilson; Sarah W Feldstein Ewing Journal: Children (Basel) Date: 2022-05-11
Authors: Meehoh Kim; David Suh; Joseph A Barone; Sun-Young Jung; Wenchen Wu; Dong-Churl Suh Journal: Int J Environ Res Public Health Date: 2022-05-30 Impact factor: 4.614
Authors: Danielle M McCarthy; Laura M Curtis; D Mark Courtney; Kenzie A Cameron; Patrick M Lank; Howard S Kim; Lauren A Opsasnick; Abbie E Lyden; Stephanie J Gravenor; Andrea M Russell; Morgan R Eifler; Scott I Hur; Megan E Rowland; Surrey M Walton; Enid Montague; Kwang-Youn A Kim; Michael S Wolf Journal: Acad Emerg Med Date: 2019-11-19 Impact factor: 3.451
Authors: Jared W Magnani; Mahasin S Mujahid; Herbert D Aronow; Crystal W Cené; Victoria Vaughan Dickson; Edward Havranek; Lewis B Morgenstern; Michael K Paasche-Orlow; Amy Pollak; Joshua Z Willey Journal: Circulation Date: 2018-06-04 Impact factor: 29.690